Jan Menne - Concepedia

Author

Jan Menne

Also Known As

Frank Vetter, Hermann Haller, J Menne, J. Menne, Jan J Menne, Jan Menne, Jan Schmieszek, Jeff Menne, Julia Menne, Menne, Jan

140

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover Charité - Universitätsmedizin Berlin University of Cologne Sorbonne Université Alexion Pharmaceuticals (United States)

About

Jan Menne is an author at Medizinische Hochschule Hannover specializing in medicine, urology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	2.4K
2	Cell Biology	6	6	1.8K
3	Health Sciences	3	3	186
4	Allergy	2	2	24
5	Public Health	1	1	37

Jan Menne

Publications

Citations

H-Index

Page 1

	Year	Citations
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice Marek Dráb, Paul Verkade, Marlies Elger, Science Lung InflammationNitric OxideGeneticsPulmonary DefectsCalcium Signaling	2001	1.5K
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome Christophe Legendre, Christoph Licht, Petra Muus, New England Journal of Medicine	2013	1.5K
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study Jan Menne, Martin Nitschke, Robert Stingele, BMJ	2012	303
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial Fádi Fakhouri, Maryvonne Hourmant, Josep M. Campistol, American Journal of Kidney Diseases	2016	298
Uremia causes endothelial progenitor cell deficiency Kirsten de Groot, Ferdinand H. Bahlmann, Johanna Sowa, Kidney International Endothelial Cell PathobiologyGlomerulonephritisUrologyMedicineHematology	2004	210
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment Éric Rondeau, Marie Scully, Gema Ariceta, Kidney International	2020	203
Low-Dose Therapy With the Long-Acting Erythropoietin Analogue Darbepoetin Alpha Persistently Activates Endothelial Akt and Attenuates Progressive Organ Failure Ferdinand H. Bahlmann, Song Rong, Sascha M. Boehm, Circulation	2004	189
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study Jan Menne, Yahsou Delmas, Fádi Fakhouri, BMC Nephrology	2019	124
Complement 5a Receptor Inhibition Improves Renal Allograft Survival Faikah Gueler, Song Rong, Wilfried Gwinner, Journal of the American Society of Nephrology ImmunologyTransplantation MedicineRenal InflammationImmunotherapyInflammation	2008	114
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Blood Advances Real-world DataImmunologyPharmacotherapyImmunotherapyThrombosis	2020	113

Page 1